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Although a considerable amount of investigation has been 
concerned with the transmission of tumors and leukemia,s from 
one animal to another, it has been noted that most of the work 
with transmissible leukemia has been done with mice, and com¬ 
paratively little with rats. Also noted was the fact that 
these studies in the mouse, particularly in the past few years, 
have concentrated on the use of cell-free filtrates of leukemic 
material, which have been shown to produce leukemia upon in¬ 
jection into the recipient mice. The rat studies have invol¬ 
ved the use of carcinogenic agents to produce leukemia, and 
the transplantation of the induced leukemia by injection of 
leukemic tissue. 
Since previous studies in the transmission of rat leukemia 
have involved only the injection of leukemic material, the 
question arose as to the possibility of other means of trans¬ 
mission, especially in the light of discoveries which strongly 
suggest a, viral etiology, at least in mice, in whom transmission 
occurs without the use of particulate matter. Therefore, it 
was decided to make an attempt to transfer rat leukemia via the 
lungs and the gastro-intestinal tract, and to see if radiation 
and the use of hydrocortisone had any effect on the transmiss- 
ibility by these routes. 
The rats used in this study were inbred albino rats of the 
WR strain, in whom an acute lympocytic leukemia was developed 
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jected into normal adult rats of the same strain, there is 
virtually one hundred per cent transmission of leukemia to 
the recipient animals. 
During the course of the experiment, a group of Sprague- 
Dawley rats instead of WR rats was irradiated by accident. 
It was therefore decided to use these as recipient animals 
for intraperitoneal injections of leukemic cells from the WR 
rats, to see if it were nossible to transmit this leukemia to 








In recent years, the induction and transfer of leukemia 
in animals, particularly mice and rats, has gained much in¬ 
terest. While spontaneous leukemia is quite rare in the rat, 
it has been found in mice. The AK strain of mice, which has 
a high incidence of soontaneous lekemia, has been used exten- 
sively in transmission experiments. Furth, in 1935, was the 
first to describe the transfer of myelogenous leukemia in 
mice (l). In 1937, Furth and Kahn succeeded in transferring 
mouse leukemia by injection of a single cell, but not by cell- 
free extracts (2). Much work has been done by Gross, using 
the AK strain. He reported the transmission of leukemia by 
inoculation of cell suspensions from leukemic AK mice into 
newborn C3H mice, which have a low incidence of soontaneous 
leukemia (3). Stewart obtained similar results (4). Gross 
was also able to transmit the AK leukemia to the C57 strain, 
and noted that susceotibility of the C3H and 057 mice to the 
transplanted leukemia declined markedly after the first’week 
of life (5). 
Although chicken lymohomatosis was transmitted by Bang 
and Ellerman in 1908 by the use of cell-free extracts (6), it 
was not until Gross in 1951 reported the transmission of 
mouse leukemia by injection of cell-free extracts (7), that 
any interest was evinced in this method of transferring mouse 
leukemia. Since that time, numerous experiments have been 
performed by Gross and others, using cell-free filtrates of 
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leukemic mouse organs. 
Comparatively little work has been done in the field of 
rat leukemia. Before 1936, leukemia had not yet been reported 
in any strain of rat. In that year Wilens and Sproul described 
myelogenous and lympa.tic leukemia in a group of Osborne-Mendel 
rats, Oberling, Guerin, and Guerin, in 1939, also described 
several cases of leukemia among a. group of rats, and Aral, in 
1940, found a case of myelogenous leukemia in a large colony of 
rats among which 27 ha.d developed spontaneous tumors (8). 
Spontaneous leukemia occurs rarely in Wistar rats, according 
to Gruenstein and Shay (9), and Sha.y et al. have noted that 
spontaneous myelogenous leukemia has never been reported in 
this strain (8). 
The induction of both myelogenous and lymphatic leukemia . 
in rats by the use of carcinogenic agents has been reported by 
several investigators. Murphy and Sturm were the first to re¬ 
port transplantable lymphatic leukemia, induced by the injec¬ 
tion of a Wistar rat with 1,2,5,6-dibenzanthracene. When leu¬ 
kemic cells were injected intraperitoneally into other Wistar 
rats, the recipients developed lymphatic leukemia with involve¬ 
ment of the lymph nodes and thymus. Subcutaneous injection 
produced local lyphosarcomas with involvement of local lymph 
nodes, and innoculation into the spleen produced leukemia with 
involvement of the spleen and liver (10). 
Shay et al. reported the developement of several cases of 
lymphatic and myelogenous leukemia among a group of Wistar rats 
■ 
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following the gastric instillation of methylcholanthrene over 
a period of 1 to 14 months (ll). These investigators have 
been able to transfer both tyres of leukemia to normal Wistar 
rats and also to rats of the Sherman and Long-Evans strains (8). 
They found that sucessful transfer occured in a very high per¬ 
centage of cases when receoients 1 to 7 days old were used, 
and that the number of sucessful transfers declined sharply 
with age, a phenomenon noted by Gross working with the trans¬ 
mission of mouse leukemia (5). The methods used for transfer 
were subcutaneous and intraperitoneal injection of whole blood, 
and spleen, liver, lymph nodes, and thymus (9). It was found 
that the virulence of the leukemia increased on repeated trans¬ 
fer, as it has been found to do in mice (12). 
Furth has developed an acute lymphocytic leukemia in an 
inbred Wistar strain of albino rats. This leukemia is trans¬ 
missible to adult rats of the same strain, and has been trans¬ 
planted by the use of intramuscular and intraperitoneal injec¬ 
tion of blood and organs from leukemic animals. Leukemia de>“ 
velopes in the host animals in 10 to 14 days, and the period 
of survival varies from 10 to 30 days. It has been found on 
repeated transfer, the leukemia has become more virulent, as 
is the case with other transmissible leukemias. The advan¬ 
tages of using the WR leukemia for these studies are its high 
degree of transmissibility end its ability to infect adult 
recepients. 




iation may enhance immunity, large doses will decrease the 
immune response (13). This has been demonstrated in various 
mammals, in whom there has been found lowered resistance to 
induced infections and to natural inhabitants of-the intes¬ 
tine, after large doses of total body irradiation. It is 
possible to transmit leukemia to resistant strains of mice by 
prior irradiation (l4),(l5), and the transmission of mouse 
leukemia to rats has been accomplished by the use of X-radia¬ 
tion (16). Hektoen, Dixon et al., and others have' found that 
the inhibitory effect of radiation on the antibody response 
depends on radiation-induced changes which occur prior to the 
administration of antigen, and that radiation has little effect 
on antibodies already formed (17),(18), Kohn has shown a 
striking reduction in the antibody response to injected sheep 
cells in rats previously irradiated with 350r. When radiation 
was delivered several days after injection the dose,had to be 
doubled in order to obtain the same reduction in antibodies, 
and the reduction was found to be transient (19). 
The mechanism by which radiation decreases immunity has 
been explained on the basis of several factors: injury to the 
phagocytic mechanism, decreased formation of antibodies, and 
destruction of lymphocytes (13). 
There is much conflicting evidence in regard to the re¬ 
lationship between adrenal cortical hormones and antibody pro¬ 
duction. Some investigators have claimed that adrenal cortical 
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observed no effect on antibody levels. However, most of the 
evidence now seems to be in accord with the theory that these 
hormones depress antibody formation. Berglund has shown that 
a significant reduction in antibody formation is produced by 
cortisone administration before injection of antigen, and that 
no significant change in antibodies is found if cortisone is 
administered after antigen injection (20). Cortisone was also 
found to decrease antibody formation in vitro (2l). Hydro¬ 
cortisone has been shown to be capable of reversing the elec¬ 
trical charge change wrought on the red cell by antibody 
action in vitro (22). Taking advantage of this property of 
cortisone, Werder et al. were able to transplant leukemia to 
a previously resistent strain of mice by prior injection of 
cortisone (l4). Similarly, Braunsteiner and Pakesch observed 
the growth of human leukemic cells in rats previously treated 
with cortisone and nitrogen mustard (23). However, in con¬ 
trast with these results, Murohy and Sturm found that adrenal¬ 
ectomy increased the susceptibility of rats to a transplantable 
lymphatic leukemia and. that the administration of ACTH and 
cortical extracts gave protection against leukemia in a highly 
susceptible strain of rats (24),(25). 
In view of the results obtained by previous investigators 
working with cortisone and irradiation, it was felt that the 
use of these methods of reducing resistance might facilitate 
the transmission of leukemia in rats. 
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EXPERI MENTAL PROCEDURE 
EXPERIMENT I. ATTEMPTS AT TRANSMISSION OF WR LEUKEMIA VIA THE 
G.A.5TRQ-INTESTINAL TRACT AND LUNGS. 
A. Preparation of leukemic organ homogenate 
In order to obtain the leukemic material, leukemic WR 
rats, their total white blood counts averaging about 300,000 
wbc/mm , were sacrificed. Each was anesthetised with 0.1 to 
0.2 cc. of Nembutal and its abdomen opened; about 6 cc of blood 
was withdrawn by intercardiac puncture through the diaphram. 
Then the liver and soleen were removed, cut into small pieces, 
and squeezed through a garlic press. A small amount of normal 
saline was added, and the mixture was strained through gauze 
to remove any strands of connective tissue or large pieces of 
material. The oxalated blood was then added to the organ hom- • 
ogenate. In each case, the homogenate was used within an hour 
of its preparation. 
B. Transmission via Inhalation 
In this experiment, 12 normal adult WR rats were used. 
Four of these were irradiated with 300r 3 days before inhal¬ 
ation of leukemic material and 4 were injected intraoeriton- 
eally with Solu-corter (hydrocortisone sodium succinate) 10 mg/ 
kilo, on two successive days, three days before inhalation. 
The other 4 animals received no pre-treatment. 
For the purposed of exposing the animals to a fine mist 
of the leukemic organ homogenate, so that they might inhale it 
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for several hours, a few cc. of the mixture were placed in a 
glass nebulizer which was connected by rubber tubing to an air 
jet. The nebulizer was taped to the rat cage, which was placed 
in a clear plastic bag, the bag was tied securely around the 
tubing so that it was airtight save for the inlet tubing from 
the air jet to the nebulizer and an outlet tube leading into a 
container of water. When the air jet was turned on, a fine 
mist was produced, and this was maintained for a period of about 
2 hours. 
Total white blood counts were performed before, and then 
3 weeks after the animals were treated. 
C. Transmission via the gastro-intestinal tract 
Eleven normal adult WR rats were used. Four animals 
were ore-treated with hydro-cortisone and four were irradiated 
with 300r, in the same manner as described in section B. Three 
other rats received no treatment previous to feeding with the 
leukemic organ homogenate. 
In order to feed the leukemic homogenate, the rats were 
Intubated, and the material injected from a syringe into the 
feeding tube (26). The animal was laid on its side and held 
down with the left hand. The left thumb was placed at the 
angle of the jaw in order to pull open the mouth. A jj8 soft 
rubber French catheter, moistened with water, was then intro¬ 
duced into the stomach with the right hand, and 2 cc. of the 
leukemic organ homogenate were injected. 








men t, and then 3 weeks afterward. 
EXPERIMENT II. CROSS-STRAIN TRANSMISSION OF WR LEUKEMIA 
Fourteen normal a.dult Sprague-Dawley rats were used In 
this experiment. Each animal was injected intraperitoneally 
with about 3 cc. of the leukemic organ homogenate. Sight rats 
were irradiated with 300r 6 days prior to injection, and the 
other group of 6 animals received no pre-treatment. Total 
white blood counts were done before injection and then at 3 
and 4 weeks after injection. 
- 
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EXPERIMENT I. ATTEMPTS AT TRANSMISSION OF LEUKEMIA TO WR 
RATS VIA THE LUNG-3 AND GA5TRO-INTESTINAL TRACT. 
- A. Transmlsslon via Inhalation 
The results of this experiment, as seen in table I, 
show that the 12 'WR rats which were exposed to a fine mist 
of the leukemic homogenate did not develope leukemia. The 
total white hlood count of all the animals in each of the 3 
groups (control, irradiated and hydrocortisone-treated) re¬ 
mained essentially the same at 3 weeks and their smears showed 
no leukemic cells. All the animals in each of the 3 groups 
were alive and showed no signs of leukemia after nearly 2 
months, except for one in the irradiated group and one in the 
hydrocortisone-treated group, who died during the fourth week 
after treatment. Death occurred without either of the 2 rats 
showing any evidence of leukemia. Unfortunately, these were 





TOTAL LEUKOCYTE COUNTS* OF WR RATS TREATED BY INHALATION OF 
LEUKEMIC HOMOSENATE 
A. Controls (no nr©-treatment) 
# normal 3 weeks 
1 6,600 5,050 
2 8,850 8,100 
3 12,500 15,450 
4 9,800 16,250 
Pre-treated with 30Or 
# normal 3 weeks 
1 19,600 18,550 
2 12,800 13,750 
3 13,950 14,000 
4 13,500 12,650 
Pre-treated with hydrocortisone 
# normal 3 weeks 
1 13.050 12,900 
2 16,750 16,850 
3 14,000 13,650 













B. Transmission via the castro-Intestinal tract 
Of the 11 WR rats that were intubated and fed the leu¬ 
kemic organ mixture, none in any croup (control, irradiated, 
and hydroeortisone-treated) developed leukemia. Their total 
white counts remained normal and their smears showed no ab¬ 
normal cells at 3 weeks. All animals were alive and healthy 
2 months after treatment. 
TABlLS II 
TOTAL LEUKOCYTE COUNTSOF WR RATS TREATED EY FEEDING OF LEU¬ 
KEMIC HOMOGENATE 
A. Controls (no pre-treatment) 
Normal 3 weeks 
1 21,950 16,750 
2 17,650 17,050 
3 13,050 15,500 
Pre-treated with 300r 
# Normal 3 weeks 
1 11,650 11,050 
2 12,050 13,400 
3 14,300 14,000 
4 12,450 14,600 
Pre-treatment with hydrocortisone 
# normal 3 weeks 
1 13,900 15,050 
2 15,150 16,100 
3 12,400 11,250 
4 13,350 14,500 
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EXPERIMENT II. CROSS-STRAIN TRANSMISSION OF WR LEUKEMIA 
Fourteen normal adult Sprague-Dawley rats were given intra- 
perltoneal Injections of leukemic organ homogenates obtained 
from leukemic rats. G-roup A received no treatment before in¬ 
jection and Group B received 300r 6 days prior to injection. 
A. Untreated rats 
In Grouo a the ore-injection total white counts ranged 
•z 
between 22,000 and 30,150 wbc/mmv. Counts done 3 weeks after 
the injection of leukemic material showed no significant change, 
nor did the smears reveal any leukemic cells. However, two of 
the animals, (#5 & 6), appeared sick and died between the third 
and fourth week after injection. Counts repeated at four weeks 
on the 4 remaining animals showed little variation In total 
white count, save for one animal (#3), whose count dropped from 
20,050 to 15,150 at 4 weeks. Inspection of a smear showed no 
abnormal cells. This animal also appeared sick, and subsequently 
died. At 5 weeks, 3 animals were still alive and appeared 
healthy. Their total white counts showed little change, and no 
leukemic cells were seen in the stained smears. 
B. Rats pre-treated with 300r 
Before irradiation, the total white counts of these rats 
ranged between 11,650 and 27,600 wbc/mm". Three weeks after 
intraperitoneal injection of leukemic homogenate, 2 animals had 
died and 3 Had become leukemic, with total white counts of 
250,000, 325,650, and 200,350. Two other anima.ls (#7 & 8) still 
had normal white counts. #6 was thought to have developed a 
tumor in the abdominal wall at the site of injection, so it was 

-15- 
sacrlficed at this time. However, on inspection, the tumor was 
found to be an abscess. At 4 weeks the leukemic animals had 
died, leaving only 2 animals (#7 & 8), whose counts were still 
normal. 
TABLE III 
TOTAL LEUKOCYTE COUNTS* OF SPRAGUE-PAULEY RATS INJECTED INTRA- 
PERI TONE ALLY WITH LEUKEMIC HOMOGENATE. 
A. No pre-treatment 
Normal 3 weeks - 4 weeks 5 weeks 
l 22,000 21,700 20,200 16,350 
2 30,150 29,350 26,250 25,200 
•2, 
J 22,500 20,500 15,150 Died 
4 24,200 24,000 23,400 23,050 
5 23,750 21,050 Died - 
6 22,350 24,300 Died - 
Pre- treated with 300 r 
* Normal 3 weeks 4 weeks 
1 11,800 Died - 
2 27,600 250,000 Died 
3 11,650 325,650 Died 
4 12,250 Died - 
5 19,950 200,350 Died 
6 12,550 Sacrificed - 
7 19,600 17,950 14,050 





I-WR STRAIN RATS 
It is evident from the observations that no rats in this 
group developed leukemia when transmission was attempted by 
feeding or by inhalation of leukemic cells. The use of hydro¬ 
cortisone and irradiation in order to diminish antibody re¬ 
sponse did not appear to increase the susceptibility. It was 
noted that of a group of 23 rats used in this part of the ex¬ 
periment, only 2 died, both of which had been treated by in¬ 
halation of leukemic cells, one having been given hydrocorti¬ 
sone previously, and the other having been exposed to 300r. 
Both animals had had normal total white counts at 3 weeks, 
with no evidence of leukemic cells in their smears, and they 
appeared perfectly healthy. Sometime during the fourth week, 
however, they had disappeared, and it was assumed that they 
had died and been removed, so that they were not available 
for autopsy. Since it is probable that these animals would 
have begun showing signs of leukemia at least a week before 
death, it is not likely that they died of leukemia, but rather 
of other causes. 
Although cell-free transmission of this leukemia has not 
been attempted, it is possible that the etiology is viral, as 
in the AK mouse leukemia, and that transfer may be effected 
by the use of cell-free filtrates. If this is the case, it 
would appear likely that transmission through the lungs and 
gastro-intestinal tract is possible, even though there may be 
: 
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destruction of the leukemic cells introduced into these organs. 
On the other hand, local inactivation of the leukemic factor, 
especially in the gastro-intestinal tract by the action of acid 
or enzymes, is very likely. Gross has shown that the mouse 
leukemic factor can be inactivated by heating (27), and by the 
addition of ether (28). Therefore it seems probable that there 
are many factors in the body which may render an animal resis¬ 
tant. It was thought that hydrocortisone or irradiation might 
lower the antibody resnonse and thereby increase the suscept¬ 
ibility to leukemia, but it is evident from the results that 
other factors are involved as well. It is probable, too, that 
adrenal cortical hormones and irradiation have other effects 
on resistance, and that the mechanism whereby the susceptibility 
of an animal to transolanted leukemia is altered, may not be 
wholly a function of decreased antibody resnonse. 
If the two rats that died of unknown causes did have leu¬ 
kemia, it is worth noting that both these animals had been sub¬ 
jected to previous treatment, one to hydrocortisone and the 
other to irradiation, and that both had inhaled the leukemic 
material. This would suggest that lowering of the antibody 
response had increased their susceptibility, and that of the 
two methods of transfer, inhalation was the more successful. 
Lowering of the antibody response may have decreased their 
resistance to infection, and this may well have been the cause 
of death. In any event, however, deflnate conclusions cannot 
be drawn from so small a series as to the effectiveness of 














these methods of transmission. 
It would be of great interest to investigate the effec¬ 
tiveness of transfer via the lungs and intestine under con¬ 
ditions in which the integrity of the alveolar membrane and 
intestinal mucosa had been damaged, such as by the administra¬ 
tion of irritants. 
II-SPRAGUE^PAWLEY RATS 
The results obtained after intraperitoneal injection of 
WR leukemic cells into Sprague-Sawley rats deomonstrate that 
this leukemia is transmissible to another strain of rats. In 
the non-irradiated control group, 3 animals of 6 were still 
alive and showed no evidence of leukemia after 5 weeks. Two 
other animals died at about 4 weeks and 1 at 5 weeks. These 
rats appeared sick, but their total white counts were not el¬ 
evated 'and their smears showed no leukemic cells. Unfortun¬ 
ately, the cause of death was not ascertained in these animals 
even though the blood was normal in all cases x^ithin a week of 
death, there is a nossibility that leukemia developed very 
rapidly and oroduced death in the space of a week. However, 
there was no evidence of leukemia in any of the 6 rats at 3 
weeks. In contrast to these results, among the group of 8 
animals previously irradiated, it was found that 3 weeks after 
injection of leukemic cells, 2 had died and 3 were definately 
leukemic, with counts between 250,000 and 325,650 per cubic 
millimeter. The three leukemic animals died within the fol¬ 
lowing week. Of the 3 rats alive at 3 weeks, one was sacrif- 
- - 
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iced because it was thought to have a tumor in the abdominal 
wall, (this was found to be an abscess), and the 2 remaining 
animals were normal. These were still alive and not leukemic 
more than 4 weeks "after injection. These results suggest 
that previous irradiation is necessary for the transmission 
of WR leukemia to Sorague-Dawley rats. If the cause of death 
in those non-irradiated rats that died was leukemia, then it 
may be assumed that radiation is not a necessary factor. How¬ 
ever, comoarison of the results in both groups suggests that 
although radiation may not be the deciding factor, it hastens 
the development of leukemia, as it can be seen that all of the 
non-irradiated group showed no signs of leukemia at 3 weeks 
after injection, while 2 of the irradiated group had already 
died and 3 others were definately leukemic at that time. 
It is not too suprising that WR leukemia could be trans¬ 
mitted to a different strain of rats, in the light of previous 
investigations. Gross, working with mouse leukemia, was able 
to transmit it from AK mice to the C3H and C57 strains (3), 
(5)» Shay et al, transmitted leukemia induced by methylchol- 
anthrene in Wistar rats to rats of the Sherman and Long-Svans 
strains (29). Kaalund-Jorgenson, in 1940, reported the trans¬ 
fer of mouse leukemia to rats after irradiation, and Pakesch 
a.nd Braunsteiner in 1955 observed the growth of human leukemia 
cells in rats previously treated, with nitrogen mustard and 
cortisone (16),(23). 
Gross has shown that when cell suspensions or cell-free 
_ ' . 
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extracts of AK mouse leukemia were inoculated into newborn 
C3H mice, leukemia developed 2 to 4 weeks later. This leuk¬ 
emia could be grafted back to the AK mice, but not to adult 
C3H mice. When filtered extracts of AK leukemia were inoc¬ 
ulated into C3H newborns, the leukemia which developed in 
some after to 27 months, was found to be specific for the 
recipient strain and could be transplanted to adult C3H mice, 
but only occasionally back to the AK strain. These results 
suggested to dross that the agent causing leukemia in the 
C3H mice was a cell-free, transmissible agent which acted on 
the cells of its new host. Experiments using C57 mice yielded 
similar results (30). 
Keeping in mind the theory proposed by dross, it would 
be of interest to see whether or not the Wft rat leukemia is 
transmissible to other strains by injection of cell-free fil¬ 
trates, and to observe the results of grafting the induced WR 
leukemia in Sprague-Dawley rats back to WR rats and also to 
to other rats of the Sprague-Dawley strain. 
• ; ; - fr 
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SUMMARY 
1. Under the conditions of this experiment, it was found that 
acute lynrohocytic leukemia was not transmissible from WR 
rats to normal rats of the same strain, via the lungs or 
gastro-intestinal tract. 
2. Pre-treatment of WR rats with hydrocortisone and irradia¬ 
tion did not appear to reduce their resistance to infection 
with leukemia via the lungs or gastro-intestinal tract. 
3. Cross-strain transmission of WR leukemia was effected by 
intraperitoneal injection-of leukemic organ homogenates 
into Sorague-Dawley rats. 
4. The results of this study suggest that cross-strain trans¬ 
mission of leukemia is facilitated by pre-treatment of the 
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